KIF4A and central nervous system cancer: Overall, we believe that through future in-depth research, WZ-3146 may be used for adjuvant chemotherapy for glioma.Meanwhile, we have only demonstrated that WZ-3146 could suppress glioma progression by inhibiting KIF4A expression in vitro.